Università di Ferrara - Tecnopolo Universtità di Ferrara Universtità di Ferrara
 

     
 

Tariffario

 
     
[ Italiano | English ]

Pubblicazioni

  • Agnoletto C, Melloni E, Casciano F, Rigolin GM, Rimondi E, Celeghini C, Brunelli L, Cuneo A, Secchiero P, Zauli G (2014) Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3. Oncotarget 5:4347-60. PubMed
  • Rimondi E, Secchiero P, Melloni E, Grill V, Zauli G (2013) Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1. Invest New Drugs 31:780-6. PubMed
  • Rimondi E, di Iasio MG, Gonelli A, Celeghini C, Secchiero P, Zauli G (2012) Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells. Invest New Drugs 30:1731-5. PubMed
  • Zauli G, Celeghini C, Melloni E, Voltan R, Ongari M, Tiribelli M, di Iasio MG, Lanza F, Secchiero P (2012) The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status. Haematologica 97:1722-30. PubMed
  • Comar M, Cuneo A, Maestri I, Melloni E, Pozzato G, Soffritti O, Secchiero P, Zauli G (2012) Merkel-cell polyomavirus (MCPyV) is rarely associated to B-chronic lymphocytic leukemia (1 out of 50) samples and occurs late in the natural history of the disease. J. Clin. Virol. 55:367-9. PubMed
  • Corallini F, Celeghini C, Rimondi E, di Iasio MG, Gonelli A, Secchiero P, Zauli G (2011) Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. J. Cell. Physiol. 226:2279-86. PubMed
  • Secchiero P, Voltan R, di Iasio MG, Melloni E, Tiribelli M, Zauli G (2010) The oncogene DEK promotes leukemic cell survival and is downregulated by both Nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells. Clin. Cancer Res. 16:1824-33. PubMed
  • Secchiero P, di Iasio MG, Melloni E, Voltan R, Celeghini C, Tiribelli M, Dal Bo M, Gattei V, Zauli G (2010) The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia. Leukemia 24:480-3. PubMed
  • Zauli G, Toffoli B, di Iasio MG, Celeghini C, Fabris B, Secchiero P (2010) Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes. Diabetes 59:1261-5. PubMed
  • Secchiero P, Melloni E, di Iasio MG, Tiribelli M, Rimondi E, Corallini F, Gattei V, Zauli G (2009) Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism. Blood 113:4300-8. PubMed
  • di Iasio MG, Secchiero P, Tiribelli M, Zauli G (2009) Reduced expression of cell cycle-associated genes in B lymphocytes purified from the peripheral blood of early-stage B chronic lymphocytic leukaemia patients. Br. J. Haematol. 145:424-6; author reply . PubMed
  • Zauli G, di Iasio MG, Secchiero P, Dal Bo M, Marconi D, Bomben R, Del Poeta G, Gattei V (2009) Exposure of B cell chronic lymphocytic leukemia (B-CLL) cells to nutlin-3 induces a characteristic gene expression profile, which correlates with nutlin-3-mediated cytotoxicity. Curr Cancer Drug Targets 9:510-8. PubMed
  • Secchiero P, Melloni E, Corallini F, Beltrami AP, Alviano F, Milani D, D'Aurizio F, di Iasio MG, Cesselli D, Bagnara GP, Zauli G (2008) Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells. Stem Cells 26:2955-63. PubMed
  • Secchiero P, Corallini F, Rimondi E, Chiaruttini C, di Iasio MG, Rustighi A, Del Sal G, Zauli G (2008) Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells. Blood 111:1287-94. PubMed
  • Secchiero P, di Iasio MG, Gonelli A, Zauli G (2008) The MDM2 inhibitor Nutlins as an innovative therapeutic tool for the treatment of haematological malignancies. Curr. Pharm. Des. 14:2100-10. PubMed
 
ASTER Por-Fesr Universtità di Ferrara